AI assistant
Sending…
RESMED INC — Director's Dealing 2018
Nov 26, 2018
30071_dirs_2018-11-26_54ae899e-f69e-4e47-a030-a52422f34b26.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-11-21
Reporting Person: McHale Richard (President, RC Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-21 | ResMed Common Stock | A | 12793 | $104.18 | Acquired | 32444 | Direct |
| 2018-11-21 | ResMed Common Stock | F | 7137 | $104.18 | Disposed | 25307 | Direct |
Footnotes
F1: Represents performance-based restricted stock units granted on November 19, 2015. The shares were earned on November 21, 2018, when the compensation committee certified that the performance metrics were met.
F2: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29